Yoshinori Hashimoto

15PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesGene and molecular therapyCardiology (incl. cardiovascular diseases)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 20, 2026
Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.

|Nov 05, 2025
Real-world evidence from Japan in patients with hematological malignancies and secondary hypogammaglobulinemia treated with 20% subcutaneous immunoglobulin, Ig20Gly: A retrospective cohort study.

Yoshinori Hashimoto, Saaya Hosoda, Hiromi Omura

|Jul 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh

|Nov 15, 2024
A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

Chiho Furuya, Yoshinori Hashimoto, Soji Morishita

|Apr 15, 2024
Sailing in deceptive calm: Navigating the undercurrents of essential thrombocythaemia.

Yoshinori Hashimoto, Alessandro Lucchesi

|Feb 16, 2024
Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia.

Yoshinori Hashimoto, Hiromi Omura, Takayuki Tanaka

Pageof 3

Frequent Collaborators

7 joint publications

Norio Komatsu

6 joint publications

Marito Araki

6 joint publications

Soji Morishita

6 joint publications

Yoko Edahiro